Dr Adrien K Strickland, MD | |
605 Glenwood Dr, Suite 404, Chattanooga, TN 37404-1108 | |
(423) 629-7220 | |
(423) 629-4091 |
Full Name | Dr Adrien K Strickland |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 605 Glenwood Dr, Chattanooga, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225230162 | NPI | - | NPPES |
1518511 | Medicaid | TN | |
7100450090 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 45586 (Tennessee) | Secondary |
207R00000X | Internal Medicine | 45586 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Adrien K Strickland, MD 605 Glenwood Dr, Suite 404, Chattanooga, TN 37404-1108 Ph: (423) 629-7220 | Dr Adrien K Strickland, MD 605 Glenwood Dr, Suite 404, Chattanooga, TN 37404-1108 Ph: (423) 629-7220 |
News Archive
"The World Health Organization warned Monday that the battle against the age-old scourge of leprosy is not yet over, with more than 5,000 new cases reported yearly in the Western Pacific, where the disease was declared eliminated in 1991," the Associated Press/Washington Post reports (2/13).
A new meta-analysis from Iran, available on the medRxiv preprint server, showed that the blood group A could be considered a partial risk factor for infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whereas the blood group O may act as a protective factor; conversely, no significant associations were observed between specific blood groups and coronavirus disease (COVID-19) mortality.
New research led by Mina Tadrous, Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto shows that use of prescription stimulant medications in older adults increased the risk of a cardiovascular events by 40 per cent within the first thirty days of medication use.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of a Phase 2b clinical study of TC-5214 as a treatment for overactive bladder.
› Verified 8 days ago
Dr. Pamela Rani Sud, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Drive, Suite E-500, Chattanooga, TN 37404 Phone: 423-495-2635 Fax: 423-495-2638 | |
David Shved, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-5179 Fax: 423-778-2108 | |
Megan J Coylewright, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-8258 | |
Dr. Charles Robert Bosshardt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2515 Desales Ave Ste 206, Chattanooga, TN 37404 Phone: 423-698-8101 Fax: 423-698-3450 | |
Dr. Elise Helene Marshall, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 Glenwood Dr Ste 300, Chattanooga, TN 37404 Phone: 423-495-2690 Fax: 423-495-2698 | |
Dr. Joshua Warner Hornsby, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 979 E 3rd St Ste A-440, Chattanooga, TN 37403 Phone: 423-778-2867 Fax: 423-778-2866 | |
Dr. Donald Franklin Mackler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 721 Glenwood Dr, Ste. W552, Chattanooga, TN 37404 Phone: 423-629-6258 Fax: 423-629-9531 |